Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


1 Arch Virol
2 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Hepatology
1 Int J Cancer
12 J Hepatol
1 J Interferon Cytokine Res
3 J Med Virol
1 J Virol
3 Lancet Gastroenterol Hepatol
3 PLoS One
1 Proc Natl Acad Sci U S A
2 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arch Virol

  1. PAUL C, Khera L, Kaul R
    Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion.
    Arch Virol. 2019 Mar 11. pii: 10.1007/s00705-019-04151.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  2. FELD JJ, Krassenburg LAP
    What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05518.
    PubMed     Text format     Abstract available

  3. PHAM C, Kuo A
    Minority Report: ENUMERATing Treatment of Chronic HBV Infection Among Asian-American Communities.
    Dig Dis Sci. 2019;64:289-291.
    PubMed     Text format    

    Eur J Gastroenterol Hepatol

  4. EL-MAKSOUD MA, Habeeb MR, Ghazy HF, Nomir MM, et al
    Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2019 Mar 11. doi: 10.1097/MEG.0000000000001388.
    PubMed     Text format     Abstract available


  5. HABIB S
    Letter to Editor: Flare of Autoimmune Hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy.
    Hepatology. 2019 Mar 15. doi: 10.1002/hep.30615.
    PubMed     Text format     Abstract available

    Int J Cancer

  6. SONG X, Tan S, Wu Z, Xu L, et al
    HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
    Int J Cancer. 2018;143:3120-3130.
    PubMed     Text format     Abstract available

    J Hepatol

  7. WANG J, Yu Y, Meng Z, Shen C, et al
    Reply to: "HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient".
    J Hepatol. 2018;68:849-851.
    PubMed     Text format    

  8. CAMMA C, Leandro G
    Direct antiviral agents and risk of HCC: Waiting for Godot.
    J Hepatol. 2018;68:614-616.
    PubMed     Text format    

  9. YU Y, Wang J, Li G, Shen C, et al
    Nucleos(t)ide analogue interruption: Alternative approach to intrahepatic set point for spontaneous control of HBV replication?
    J Hepatol. 2017 Oct 6. pii: S0168-8278(17)32346.
    PubMed     Text format    

  10. TOYODA H, Kumada T, Tada T, Mizuno K, et al
    Imaging basis of AFP and WFA(+)M2BP as indicators of the risk of HCC after SVR.
    J Hepatol. 2018;68:606-607.
    PubMed     Text format    

  11. GREBELY J, Swan T, Hickman M, Bruneau J, et al
    Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.
    J Hepatol. 2017 Feb 3. pii: S0168-8278(17)30054.
    PubMed     Text format    

    Consistent advice for people who inject drugs in the 2016 EASL Recommendations on treatment of hepatitis C.
    J Hepatol. 2017 Feb 3. pii: S0168-8278(17)30055.
    PubMed     Text format    

  13. NAKAO Y, Hashimoto S, Abiru S, Komori A, et al
    Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?
    J Hepatol. 2018;68:854-855.
    PubMed     Text format    

  14. MEFFERT PJ, Repp KD, Volzke H, Weiss FU, et al
    The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort.
    J Hepatol. 2018;68:858-860.
    PubMed     Text format    

  15. ALAZAWI W, Knolle PA
    Interfering with Kupffer cell replenishment: New insights into liver injury.
    J Hepatol. 2018;68:635-637.
    PubMed     Text format    

  16. WYLES D, Weiland O, Yao B, Weilert F, et al
    Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection.
    J Hepatol. 2019 Mar 8. pii: S0168-8278(19)30078.
    PubMed     Text format    

  17. WONG TC, Fung JY, Yu-Shi Cui T, Lam AH, et al
    Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    J Hepatol. 2019 Mar 11. pii: S0168-8278(19)30139.
    PubMed     Text format     Abstract available

  18. LIM YS, Gwak GY, Choi J, Lee YS, et al
    Monotherapy with Tenofovir Disoproxil Fumarate for Adefovir-Resistant vs. Entecavir-Resistant Chronic Hepatitis B: a 5-Year clinical trial.
    J Hepatol. 2019 Mar 12. pii: S0168-8278(19)30142.
    PubMed     Text format     Abstract available

    J Interferon Cytokine Res

  19. HU JH, Chang ML, Huang TJ, Yeh CT, et al
    Comparison of Compliance and Efficacy of Pegylated Interferon alpha-2a and alpha-2b in Adults with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2019 Mar 11. doi: 10.1089/jir.2018.0028.
    PubMed     Text format     Abstract available

    J Med Virol

  20. HUANG R, Rao H, Xie Q, Gao Z, et al
    Comparison of Efficacy of Sofosbuvir plus Ribavirin in Chinese Patients with Genotype 3a or 3b HCV Infection.
    J Med Virol. 2019 Mar 12. doi: 10.1002/jmv.25454.
    PubMed     Text format     Abstract available

  21. SI J, Li J, Zhang L, Zhang W, et al
    A signal amplification system on a lateral flow immunoassay detecting for hepatitis e antigen in human blood samples.
    J Med Virol. 2019 Mar 9. doi: 10.1002/jmv.25452.
    PubMed     Text format     Abstract available

  22. KOC OM, Kremer C, Bielen R, Buscchots D, et al
    Prevalence and risk factors of hepatitis B virus infection in Middle-Limburg Belgium, year 2017: importance of migration.
    J Med Virol. 2019 Mar 14. doi: 10.1002/jmv.25457.
    PubMed     Text format     Abstract available

    J Virol

  23. SHERAZ M, Cheng J, Tang L, Chang J, et al
    Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA.
    J Virol. 2019 Mar 13. pii: JVI.02230-18. doi: 10.1128/JVI.02230.
    PubMed     Text format     Abstract available

    Lancet Gastroenterol Hepatol

  24. THIJSSEN M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, et al
    Mass migration to Europe: an opportunity for elimination of hepatitis B virus?
    Lancet Gastroenterol Hepatol. 2019;4:315-323.
    PubMed     Text format     Abstract available

  25. NGUYEN-KHAC E, Thiele M, Voican C, Nahon P, et al
    Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.
    Lancet Gastroenterol Hepatol. 2018;3:614-625.
    PubMed     Text format     Abstract available

    Undiagnosed hepatitis in patients with cancer.
    Lancet Gastroenterol Hepatol. 2019;4:255.
    PubMed     Text format    

    PLoS One

  27. LE NGOC C, Tran Thi Thanh T, Tran Thi Lan P, Nguyen Mai T, et al
    Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam.
    PLoS One. 2019;14:e0212734.
    PubMed     Text format     Abstract available

  28. CHIU SY, Chung HJ, Chen YT, Huang MS, et al
    A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1.
    PLoS One. 2019;14:e0208665.
    PubMed     Text format     Abstract available

  29. JONES EA, Linas BP, Truong V, Burgess JF, et al
    Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program.
    PLoS One. 2019;14:e0213745.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  30. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Text format     Abstract available


  31. BURNY W, Marchant A, Herve C, Callegaro A, et al
    Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
    Vaccine. 2019 Mar 5. pii: S0264-410X(19)30209.
    PubMed     Text format     Abstract available

  32. MOUCHET J, Begaud B
    Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30253.
    PubMed     Text format     Abstract available


  33. LUKASH T, Freitas N, Menne S, Gudima SO, et al
    Down-regulation of hepatitis delta virus super-infection in the woodchuck model.
    Virology. 2019;531:100-113.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.